EMERGENT BIOSOLUTIONS INC. Preferred Stock, Shares Outstanding
EMERGENT BIOSOLUTIONS INC. (EBS) had Preferred Stock, Shares Outstanding of 0 shares as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure › Preferred Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:PreferredStockSharesOutstanding · last filed 2026-08-06
- 2026-06-30: Preferred Stock, Shares Outstanding 0.00 shares.
- 2026-03-31: Preferred Stock, Shares Outstanding 0.00 shares.
- 2025-12-31: Preferred Stock, Shares Outstanding 0.00 shares.
- 2025-09-30: Preferred Stock, Shares Outstanding 0.00 shares.
| Period end | Preferred Stock, Shares Outstanding |
|---|---|
| 2026-06-30 | 0.00 shares 10-Q · filed 2026-08-06 |
| 2026-03-31 | 0.00 shares 10-Q · filed 2026-05-01 |
| 2025-12-31 | 0.00 shares 10-Q · filed 2026-08-06 |
| 2025-09-30 | 0.00 shares 10-Q · filed 2025-10-30 |
| 2025-06-30 | 0.00 shares 10-Q · filed 2025-08-07 |
| 2025-03-31 | 0.00 shares 10-Q · filed 2025-05-08 |
| 2024-12-31 | 0.00 shares 10-K · filed 2026-02-27 |
| 2024-09-30 | 0.00 shares 10-Q · filed 2024-11-07 |
| 2024-06-30 | 0.00 shares 10-Q · filed 2024-08-07 |
| 2024-03-31 | 0.00 shares 10-Q · filed 2024-05-02 |
| 2023-12-31 | 0.00 shares 10-K · filed 2025-03-04 |
| 2023-09-30 | 0.00 shares 10-Q · filed 2023-12-11 |
| 2023-06-30 | 0.00 shares 10-Q · filed 2023-08-09 |
| 2023-03-31 | 0.00 shares 10-Q · filed 2023-05-10 |
| 2022-12-31 | 0.00 shares 10-K · filed 2024-03-08 |
| 2022-09-30 | 0.00 shares 10-Q · filed 2023-12-11 |
| 2022-06-30 | 0.00 shares 10-Q · filed 2022-08-02 |
| 2022-03-31 | 0.00 shares 10-Q · filed 2022-04-29 |
| 2021-12-31 | 0.00 shares 10-K/A · filed 2023-12-11 |
| 2021-09-30 | 0.00 shares 10-Q · filed 2021-11-05 |
| 2021-06-30 | 0.00 shares 10-Q · filed 2021-07-30 |
| 2021-03-31 | 0.00 shares 10-Q · filed 2021-04-30 |
| 2020-12-31 | 0.00 shares 10-K · filed 2022-02-25 |
| 2020-09-30 | 0.00 shares 10-Q · filed 2020-11-06 |
| 2020-06-30 | 0.00 shares 10-Q · filed 2020-07-31 |
| 2020-03-31 | 0.00 shares 10-Q · filed 2020-05-01 |
| 2019-12-31 | 0.00 shares 10-K · filed 2021-02-19 |
| 2019-09-30 | 0.00 shares 10-Q · filed 2019-11-07 |
| 2019-06-30 | 0.00 shares 10-Q · filed 2019-08-02 |
| 2019-03-31 | 0.00 shares 10-Q · filed 2019-05-08 |
| 2018-12-31 | 0.00 shares 10-K · filed 2020-02-25 |
| 2018-09-30 | 0.00 shares 10-Q · filed 2018-11-02 |
| 2018-06-30 | 0.00 shares 10-Q · filed 2018-08-03 |
| 2018-03-31 | 0.00 shares 10-Q · filed 2018-05-04 |
| 2017-12-31 | 0.00 shares 10-K · filed 2019-02-22 |
| 2017-09-30 | 0.00 shares 10-Q · filed 2017-11-03 |
| 2017-06-30 | 0.00 shares 10-Q · filed 2017-08-04 |
| 2017-03-31 | 0.00 shares 10-Q · filed 2017-05-05 |
| 2016-12-31 | 0.00 shares 10-K · filed 2018-02-23 |
| 2016-09-30 | 0.00 shares 10-Q · filed 2016-11-09 |
| 2016-06-30 | 0.00 shares 10-Q · filed 2016-08-05 |
| 2016-03-31 | 0.00 shares 10-Q · filed 2016-05-06 |
| 2015-12-31 | 0.00 shares 10-K · filed 2017-02-28 |
| 2015-09-30 | 0.00 shares 10-Q · filed 2015-11-06 |
| 2015-06-30 | 0.00 shares 10-Q · filed 2015-08-06 |
| 2015-03-31 | 0.00 shares 10-Q · filed 2015-05-08 |
| 2014-12-31 | 0.00 shares 10-K · filed 2016-02-29 |
| 2014-09-30 | 0.00 shares 10-Q · filed 2014-11-10 |
| 2014-06-30 | 0.00 shares 10-Q · filed 2014-08-08 |
| 2014-03-31 | 0.00 shares 10-Q · filed 2014-05-12 |
| 2013-12-31 | 0.00 shares 10-K · filed 2015-03-09 |
| 2013-09-30 | 0.00 shares 10-Q · filed 2013-11-08 |
| 2013-06-30 | 0.00 shares 10-Q · filed 2013-08-06 |
| 2013-03-31 | 0.00 shares 10-Q · filed 2013-05-03 |
| 2012-12-31 | 0.00 shares 10-K · filed 2014-03-10 |
| 2012-09-30 | 0.00 shares 10-Q · filed 2012-11-01 |
| 2012-06-30 | 0.00 shares 10-Q · filed 2012-08-03 |
| 2012-03-31 | 0.00 shares 10-Q · filed 2012-05-04 |
| 2011-12-31 | 0.00 shares 10-K · filed 2013-03-08 |
| 2011-09-30 | 0.00 shares 10-Q · filed 2011-11-04 |
| 2011-06-30 | 0.00 shares 10-Q · filed 2011-08-05 |
| 2010-12-31 | 0.00 shares 10-K · filed 2012-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |